Namsa CEO and leadership

Christophe Berthoux is an Exec VP:Global Sales & Mktg/Chief Commercial Ofcr at CHARLES RIVER LABORATORIES, Member of the Board of Directors at Synexus, and Chairman at IMAGE ANALYSIS INC and is based in London, Greater London, United Kingdom. He has worked as CEO at Synexus, Chief Executive Officer at Synexus Clinical Research Ltd, and Gen Mgr:Clinical Svcs at CHARLES RIVER LABORATORIES.

Elsa TESFAY is a Chief Project Assistant at NAMSA and is based in France. She has worked as Hôte de caisse at DECITRE, Assistant chef de produit France stage at ERIDAN, and Assistante de direction stage at Wall Street English. Elsa attended Cracker Barrel between 2011 and 2015 and Cracker Barrel between 2016 and 2018.

NAMSA is a Medical Research Organization (MRO) providing consulting, clinical trials and testing services to the global medical device industry across the continuum of product development.

Kenneth Ouriel (born October 21, 1956) is a vascular surgeon and medical researcher. He has published in scientific and medical journals. He treated former presidential candidate Bob Dole for an abdominal aortic aneurysm in 2001. In the middle 2000s, Ouriel went to Dubai as CEO to help build a world-class hospital; he treated several Middle Eastern rulers in addition to his administrative duties. In 2009, he was senior vice president and chief of international operations at New York-Presbyterian Hospital. He has been described as one of America's top vascular surgeons.